Single-Session Extraoral PBM After Third Molar Extraction
NCT: NCT07522918 · COMPLETED
Brief Summary
Postoperative pain, edema, and trismus are frequent complications following impacted mandibular third molar surgery. This randomized controlled trial evaluated the effects of a single-session extraoral dual-wavelength photobiomodulation (PBM) (650+904 nm) applied immediately after extraction. The study aimed to assess the impact of this therapy on postoperative pain, edema, trismus, and quality of life (QoL) on days 2 and 7. The results indicate that PBM effectively reduces early postoperative pain and improves QoL on the second day after surgery, although it does not significantly affect edema or trismus.
Frequently Asked Questions
What is Single-Session Extraoral PBM After Third Molar Extraction?
Single-Session Extraoral PBM After Third Molar Extraction is a clinical trial registered under NCT07522918. Current status: COMPLETED.
What is the status of NCT07522918?
The current status of NCT07522918 (Single-Session Extraoral PBM After Third Molar Extraction) is: COMPLETED.
When did Single-Session Extraoral PBM After Third Molar Extraction start?
Single-Session Extraoral PBM After Third Molar Extraction started on 2025-02-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.